ArticleBMJ open2024

How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway.

Jannicke Igland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.